Last updated on April 2020

FX-322 in Adults With Stable Sensorineural Hearing Loss


Brief description of study

This is a phase 2a single and repeat dose exploratory efficacy study of intratympanic FX-322 compared to placebo in healthy male and female adults with stable sensorineural hearing loss.

Detailed Study Description

Sensorineural hearing loss (SNHL) accounts for about 90% of all cases of hearing loss. This phase 2a study will assess the exploratory efficacy, as well as the local and systemic safety of single and repeat intratympanic doses of FX-322 compared to placebo in approximately 96 subjects with stable mild to moderately severe sensorineural hearing loss, with a medical history consistent with either excessive noise exposure or idiopathic sudden sensorineural hearing loss.

Clinical Study Identifier: NCT04120116

Find a site near you

Start Over

Clinical Trial Site

Fresno, CA United States
  Connect »

Clinical Trial Site

Torrance, CA United States
  Connect »

Clinical Trial Site

Colorado Springs, CO United States
  Connect »

Clinical Trial Site

Boca Raton, FL United States
  Connect »

Clinical Trial Site

Sarasota, FL United States
  Connect »

Clinical Trial Site

Tampa, FL United States
  Connect »

Clinical Trial Site

Louisville, KY United States
  Connect »

Clinical Trial Site

Omaha, NE United States
  Connect »

Clinical Trial Site

Amherst, NY United States
  Connect »

Clinical Trial Site

Matthews, NC United States
  Connect »

Clinical Trial Site

Winston-Salem, NC United States
  Connect »

Clinical Trial Site

Orangeburg, SC United States
  Connect »

Clinical Trial Site

San Antonio, TX United States
  Connect »

Clinical Trial Site

Salt Lake City, UT United States
  Connect »

Clinical Trial Site

Richmond, VA United States
  Connect »

Clinical Trial Site

Austin, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.